Showing 20 of 9550 recruiting trials
SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
👨⚕️ Cornelia D Cudrici, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Feb 2026View details ↗
WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
HEALEY ALS Platform Trial - Regimen I NUZ-001
Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment
Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study
RecruitingNCT07491848 ↗
Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
Ceftriaxone for Post-Treatment Lyme Disease
The ORIGIN-FH Study
Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
👨⚕️ Gabriel A. Brooks, MD, MPH, Alliance for Clinical Trials in Oncology📍 271 sites📅 Started Feb 2026View details ↗
RecruitingNCT06906367 ↗
A Study of Patients With Fabry Disease (US Specific)
Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
👨⚕️ Xiao Zhijian, Doctor, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)📍 2 sites📅 Started Feb 2026View details ↗
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →